US startup NanoTech BioSystems announces that its DNA nanocarrier drug delivery system has passed FDA preliminary review_Product Application_News

2023-11

US startup NanoTech BioSystems announces that its DNA nanocarrier drug delivery system has passed FDA preliminary review

In November 2023, the American start-up NanoTech BioSystems announced that its DNA nano cage drug delivery system had passed the preliminary review of FDA for targeted treatment of breast cancer. This technology utilizes DNA origami to construct programmable carriers, significantly reducing chemotherapy side effects, and is expected to enter phase II clinical trials by the end of 2024.

German BioNanoWorks launches world's first commercial DNA nanosensor 'DetectX'

CRISPR-Cas9 gene editing technology has achieved another breakthrough!